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ABSTRACT: Functional neuroimaging has pro-
vided new tools to study cerebral gait control in Parkin-
son’s disease (PD). First, imaging of blood flow
functions has identified a supraspinal locomotor net-
work that includes the (frontal) cortex, basal ganglia,
brainstem tegmentum, and cerebellum. These studies
also emphasize the cognitive and attentional depend-
ency of gait in PD. Furthermore, gait in PD and related
syndromes like progressive supranuclear palsy may be
associated with dysfunction of the indirect, modulatory
prefrontal–subthalamic–pedunculopontine loop of loco-
motor control. The direct, stereotyped locomotor loop
from the primary motor cortex to the spinal cord with
rhythmic cerebellar input appears to be preserved and
may contribute to the unflexible gait pattern in parkinso-
nian gait. Second, neurotransmitter and proteinopathy
imaging studies are beginning to unravel novel mecha-
nisms of parkinsonian gait and postural disturbances.
Dopamine displacement imaging studies have shown evi-
dence for a mesofrontal dopaminergic shift from a
depleted striatum in parkinsonian gait. This may place
additional burden on other brain systems mediating
attention functions to perform previously automatic motor
tasks. For example, our preliminary cholinergic imaging
studies suggest significant slowing of gait speed when
additional forebrain cholinergic denervation occurs in PD.
Cholinergic denervation of the pedunculopontine nucleus
and its thalamic projections have been associated with
falls and impaired postural control. Deposition of b-
amyloid may represent another non-dopaminergic corre-
late of gait disturbance in PD. These findings illustrate
the emergence of dopamine non-responsive gait prob-
lems to reflect the transition from a predominantly
hypodopaminergic disorder to a multisystem neurodege-
nerative disorder involving non-dopaminergic locomotor
network structures and pathologies. VC 2013 International
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Gait and postural dysfunction presents early in Par-
kinson’s disease (PD),1 is a significant cause of disabil-
ity, and responds poorly to dopaminergic replacement
except in the early phase of the disease.2 Clinical char-
acteristics of parkinsonian locomotor patterns include
a slow and small-stepped gait with reduced angular
excursion of the joints (eg shoulder, knee and trunk
joints).3,4 PD affects “complex” gait activities, such as
gait initiation, braking, and turning, which need mod-
ulation of the stereotyped (spinal) gait pattern. Akine-
sia, defined as inability to initiate movement or sustain
movement (eg “sudden freezes”), is considered by
some to be the fifth cardinal feature of PD.5 Freezing
of gait (FOG), usually manifested as abrupt cessation
of leg movement during walking, is a common cause
of falls. Sudden freezes may be related to altered corti-
cal regulation of movement execution together with
progressive impairment of mesencephalic locomotor
center function.6 The levodopa resistance of parkinso-
nian gait disturbances has been proposed to result
from the extension of the degenerative process to non-
dopaminergic structures.7 Here, we review first imag-
ing studies of locomotor network functions in PD
followed by neurochemical imaging studies that may
underlie such network changes. We also discuss
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directions for future neuroimaging research to better
understand mechanisms of parkinsonian gait distur-
bances. Specifically, we emphasize the need for future
research based on correlation of imaging studies with
improved and quantitative gait analysis assessments.
Imaging Methods and Human Mobility
Functions
Positron emission tomography (PET) and single pho-
ton emission computed tomography (SPECT) are
molecular imaging techniques that use radiolabeled
molecules to image molecular interactions of biologi-
cal processes in vivo, such as binding of neurorecep-
tors, metabolism by cerebral enzymes, or regional
cerebral blood flow (rCBF). The first in vivo human
imaging studies of locomotion were performed using a
radiotracer rCBF SPECT technique.8,9 Similar to rCBF
oxygen-15–labeled water ([15O]H2O) PET or regional
cerebral glucose metabolic [18F]fluorodeoxyglucose
(FDG) PET, these techniques suffer from poor tempo-
ral resolution and radiation exposure. The desired
characteristics of a neuroimaging technique to study
mobility include: high spatial resolution, high tempo-
ral resolution, whole brain (cortex/subcortical struc-
tures) imaging, imaging of actual gait or mobility
functions, noninvasive, portable, cheap, no side
effects, and compatible with implanted neurostimula-
tors (Table 1).
However, currently, there is no imaging modality
technique that meets all of these preferred criteria.
With the exception of functional near infrared spec-
troscopy (fNIRS) and electroencephalography (EEG),
SPECT, PET, magnetic resonance imaging (MRI), and
magnetoencephalography (MEG) cameras are not
portable. The use of functional MRI (fMRI) has
allowed unique insights into brain network changes
underlying mobility. Currently, fMRI is the only
method that allows the investigation of whole brain
activity and different gait conditions (eg gait initiation,
turning, obstacle avoidance) in the same experiment.
However, fMRI requires that the patient does not
move the head during data acquisition. To overcome
this problem, different paradigms have been developed
to record cerebral blood oxygen level-dependent
(BOLD) signals as an equivalent for brain activity dur-
ing motor planning, during repetitive foot and leg
movements, and during imagery of the motor function
(motor imagery [MI]). The latter has been proven to
be a very promising approach (for an in-depth review
of this topic, see Maillet et al.10). It is well known
that neuronal networks show a substantial overlap
between execution and imagery of a task. That is also
a reason why MI is broadly used for training motor
skills in sports and for relearning motor skills during
rehabilitation. Miyai et al. compared treadmill walk-
ing (fNIRS) and MI (fMRI) and observed overlapping
activity in the medial primary motor cortex (M1) and
the supplementary motor area.11 Recently, it was
observed that the locomotor network was very similar
between actual walking (FDG-PET) and MI (fMRI).12
Furthermore, the network is specifically activated dur-
ing imagery of active walking, but not during imagery
of passive transfer or observing a second person’s
walking.13 Based on these and other findings, MI is
increasingly used to study human locomotion.
Imaging and Mobility: Network Correlates
The spinal pattern generators that provide the basic
stepping pattern interact with sensory feedback and
supraspinal structures to ensure flexible mobility. In
analogy to cat electrophysiology and supported by
human imaging data (Fig. 1), one can assume that pre-
frontal cortical areas are important for gait initiation
and convey the locomotor signals through basal gan-
glia to brainstem locomotor regions.14–16 The subtha-
lamic locomotor region (SLR) in the lateral
hypothalamic area and the mesencephalic locomotor
region (MLR), corresponding to the cuneiform and
pedunculopontine nuclei in the dorsal midbrain, are
disinhibited from tonic basal ganglia control for gait
initiation.17 The cerebellar locomotor region (CLR),
located close to the fastigial nuclei in the cerebellar
midline, receives rhythmic input from the vermis and
paravermal cerebellar cortex to control gait speed and
variability.18 The CLR output converges with descend-
ing MLR projections in the pontine brainstem, where
TABLE 1. Desired characteristics of imaging modalities used to study mobility
Characteristic fMRI
rCBF SPECT
& FDG PET [15O]H2O PET
Neurotransmitter
PET or SPECT fNIRS MEG/EEG
Spatial resolution 111 11 1 11 1 1111
Temporal resolution 111 1/2 1 1/2 111 1111
Subcortical definition 1111 111 111 111 2 11
Actual gait 2 11 2 1 1111 1 (EEG)
Non-radioactive 1 2 2 2 1 1
Portable 2 2 2 2 1 1 (EEG)
fMRI, functional magnetic resonance imaging; rCBF, regional cerebral blood flow; SPECT, single photon emission computed tomography; FDG PET, [18F]fluoro-
deoxyglucose positron emission tomography; [15O]H2O, oxygen-15–labeled water; fNIRS, functional near infrared spectroscopy; MEG, magnetoencephalogra-
phy; EEG, electroencephalography.
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locomotor signals are transmitted to the spinal cord
spinal pattern generators. It is believed that the cere-
bellar vermis integrates proprioceptive, vestibular, and
visual afferent information into the locomotor pro-
gram. It has been postulated anatomically and physio-
logically that the pallidum has mutual connections to
the MLR.19 The frontal cortices also have connections
with the cerebellum through the thalamus and pontine
nuclei and with the basal ganglia through the basal
ganglia-thalamocortical circuit.20
Imaging Studies on Parkinsonian Gait
Using rCBF SPECT and treadmill walking, PD
patients exhibited less activity in the left medial frontal
lobe, the right precuneus, and the left cerebellar hemi-
sphere; whereas activity in the cerebellar midline, the
right insula, and the left temporal and cingulated gyri
was increased compared with controls.21,22 It is plausi-
ble that the increased activity in the insula may reflect
increased sensory control, and the increased flow in cer-
ebellar midline may compensate for frontal deficits in
parkinsonian gait. FDG-PET at rest recently was used
to assess the effect of a gait rehabilitation program in
PD.23 Before therapy, patients showed hypometabolism
in the right parietal lobe, the temporal lobes, and the
left frontal lobe. Hypermetabolism was detected in the
left cerebellum. After therapy, metabolism increased in
the right cerebellum, the right parietal lobes, and the
temporal lobes, showing an effect of the therapy both
on physical performance and on supraspinal locomotor
control. In a recent FDG-PET study of patients with
progressive supranuclear palsy, we observed dysfunc-
tion of the indirect, modulatory prefrontal-subthalamic-
pedunculopontine loop of locomotor control. The
direct, stereotyped locomotor loop from the primary
motor cortex to the spinal cord with rhythmic cerebel-
lar drive showed increased activity. This may reflect a
compensatory mechanism that also might contribute to
the stereotyped gait pattern in progressive supranuclear
palsy.24 Results of a recent fMRI study called for a
similar interpretation: PD patients had signal increases
in the right dorsal premotor area; in the precentral,
right inferior parietal lobule; and in the bilateral precu-
neus when undergoing imaging while stepping over
obstacles.25
Imaging Studies of Freezing of Gait
FOG is an extremely debilitating symptom of par-
kinsonian disorders with an unknown pathophysiolog-
ical mechanism. Several studies have tried to localize
FIG. 1. This is a schema of supraspinal locomotor control in humans. (Left) The presumed network in a healthy individual is illustrated as derived
from animal electrophysiology and human functional imaging. The indirect pathway from frontal cortex via basal ganglia to the brainstem locomotor
centers allows modulation of the gait pattern in response to external demands. The direct pathway from motor cortex to the spinal cord can bypass
the brainstem centers during undisturbed locomotion. Rhythmic input from the cerebellum conveys with both pathways in the brainstem tegmentum.
The inset indicates blood oxygen level-dependent (BOLD) signal increases during mental imagery of locomotion (see Wutte et al.13). (Right) Network
changes in PD are illustrated. The direct pathway (depicted in red) compensates for deficiencies in the indirect pathways but does not allow
adequate adaptation of gait to environmental demands. PMC indicates primary motor cortex; SMA, supplementary motor area; DLPFC, dorsolateral
prefrontal cortex; PSP, progressive supranuclear palsy; SLR, subthalamic locomotor region; MLR, mesencephalic locomotor region; CLR, cerebellar
locomotor region; PMRF, pontomedullary reticular formation [adapted from la Fougere et al.,12 Jahn et al.,16 and Zwergal et al.24].
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the altered cerebral activity associated with FOG (for
an overview, see Table 2; for a review, see Bartels and
Leenders26). These findings emphasize the disruption
of cortical (particularly orbitofrontal and parietal)
functions in patients with FOG, who also tend to have
to have more severe caudate nucleus dopaminergic
denervation.26 The involvement of typical nonmotor
cortical areas may emphasize the cognitive and atten-
tional dependency of gait in PD. However, a pitfall of
these studies is that confounding effects of comorbid
cognitive and mood changes27 in patients with FOG
cannot be excluded.
A recent resting-state fMRI brain connectivity study
identified reduced connectivity in the right cortical fron-
toparietal “executive-attention” and the right occipito-
temporal “visual” networks in patients who had PD
with FOG, suggesting a role of network connectivity
disruption.28 Furthermore, atrophy of frontal and parie-
tal gray matter occurs in patients who have PD with
FOG.29 FOG in PD seems to reflect executive dysfunc-
tion and perception deficits corresponding to changes in
frontal and parietal cortices. In accordance with those
studies and despite the limitation of studying FOG with
MI, a recent fMRI study demonstrated hypoactivation
of the frontal and parietal cortex with hyperactivation
of the MLR, pointing to a possible subcortical compen-
sation of the cortical deficit in parkinsonian FOG.6 An
fMRI study of patients who had PD with known FOG
during a timed “up-and-go” task, in which a virtual
reality gait paradigm was used, provided evidence of
dysfunction across coordinated neural networks, includ-
ing the caudate nucleus, globus pallidus pars interna,
thalamus, and MLR.27 In addition, patients with FOG
may be unable to recruit specific cortical and subcorti-
cal regions during the performance of simultaneous
motor and cognitive functions.30 These findings suggest
that the pathophysiology of freezing involves context-
dependent dysfunction across multiple levels of the
locomotor system, including cortical, subcortical, and
brainstem regions.31,32
Deep Brain Stimulation Activation Studies
and Gait in PD
Deep brain stimulation (DBS) has become a routine
treatment modality for patients with advanced PD.
The effects of subthalamic nucleus (STN) DBS on gait
and balance vary in PD, and the underlying mecha-
nisms remain unclear.33 Hill and colleagues compared
the effects of dorsal versus ventral STN regions on
gait functions in PD using [15O]H2O PET in a within-
subject design.33 Those authors observed differential
correlations with gait velocity and premotor cortex
rCBF changes using ventral STN DBS, whereas dorsal
STN DBS produced similar changes in the anterior
cerebellum. Their findings suggest that the effects of
STN DBS on gait may be mediated by different cir-
cuits, depending on the site of STN region stimulation
through basal ganglia-thalamocortical circuits versus
cerebellar-thalamocortical circuits.34 The findings also
illustrate the complementary roles of basal ganglia and
cerebellum in motor control.
Evidence that degeneration of the pedunculopontine
nucleus (PPN) occurs in PD and the important role of
the PPN in gait and postural stability, coupled with
the finding that stimulation of the PPN in animal
TABLE 2. Radiotracer imaging studies in PD patients with gait difficulties, including freezing of gait (FOG)
Imaging technique Reference Patient populations Findings
rCBF [133Xe]-SPECT5 Factor5 PD with FOG and atypical
parkinsonisms
Frontal hypoperfusion only seen in patients
with progressive supranuclear palsy but
not in PD with FOG using imaging tech-
nique with limited spatial resolution
rCBF [99mTc]-HMPAO SPECT Hanakawa et al.22 PD vs controls walking on treadmill Gait disturbance in PD was associated with
under activity in the medial motor area
and the cerebellar hemisphere, together
with over activity in the cerebellar vermis
rCBF [123I]-IMP SPECT Matsui et al.68 PD with and without FOG Decreased flow in orbitofrontal cortex (Brod-
mann area 11) in PD with FOG
rCBF [123I]-IMP SPECT Mito et al.69 PD subgroups with and without
severe gait disturbances
Hypoperfusion of the lateral frontal and tem-
poral association cortex and the medial
frontal gyrus in PD subgroup with severe
gait disturbances
FDOPA and FDG PET Bartels et al.70 PD with and without FOG Reduced caudate nucleus FDOPA and FDG
activity and reduced right parietal cortical
FDG activity in PD with FOG
rCBF [123I]-IMP SPECT Imamura et al.71 PD with and without FOG Decreased flow in bilateral Brodmann areas
10 and 11 and left 32 in PD with FOG
rCBF, regional cerebral blood flow; [133Xe]-SPECT, xenon-133 single photon emission computed tomography; [99mTc]-HMPAO, technetuim-99m–labeled hexa-
methylpropyleneamine oxime; [123I]-IMP, N-isopropyl-4-[123]iodoamphetamine; FDOPA, fluorodopa; FDG, [18F]fluorodeoxyglucose.
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models increases locomotor activity,35–37 led to inter-
est in PPN stimulation for gait and postural dysfunc-
tion in PD.38,39 A [15O]H2O PET activation study
revealed that PPN DBS was associated with rCBF
increases in the thalamus, cerebellum, midbrain
region, and cortical areas involved in balance and
motor control.40
Neurotransmitter Imaging Studies and Gait
and Postural Functions in PD
The basal ganglia and the neurotransmitter dopa-
mine have been key targets for research exploring the
pathophysiology underlying movement disorders. The
extent of nigrostriatal dopaminergic denervation can
be quantified in PD using PET or SPECT techniques
using DOPA decarboxylase, dopamine transporter
(DAT), and vesicular monoamine transporter ligands.
Such studies have demonstrated that striatal dopamine
deficiency is most closely correlated with bradykine-
sia.41 Ouchi and colleagues reported on changes in
dopamine availability in the nigrostriatal and meso-
cortical dopaminergic systems by gait in PD.42 Those
investigators used DAT PET imaging before and after
1 hour of strenuous walking in patients with PD and a
control group and observed that uptake in the stria-
tum (specifically, the putamen) was decreased by gait
to a greater extent in normal controls, whereas a sig-
nificant reduction in DAT uptake was no longer pres-
ent in the already denervated putamen but occurred in
the caudate nucleus and orbitofrontal cortex in
patients with PD. This shifted activity to predominant
nonmotor structures of the anterior striatum and the
mesocortical dopaminergic system may represent a key
element in the pathophysiology of parkinsonian gait.
Evidence is accumulating that degeneration of both
major cholinergic projection systems—the brainstem
PPN and the basal forebrain corticopetal complex—is
a major contributor to PD gait and postural dysfunc-
tion.43,44 We have observed that PPN-thalamic cholin-
ergic innervation was reduced more severely in PD
fallers compared with nonfallers,44,45 as confirmed by
postmortem findings.46 These results are consistent
with PPN degeneration as a cause of impaired postural
control in PD (Table 3). We have preliminary data
indicating that forebrain cholinergic degeneration is
associated with slower gait speed in patients with PD,
likely reflecting the degradation of attentional capaci-
ties.47 Gait speed is not significantly slower than nor-
mal in patients who have PD with predominant
nigrostriatal dopaminergic denervation. These data
suggest that forebrain cholinergic denervation is a
more robust marker of slowing of gait in PD than
nigrostriatal denervation alone and may reflect failing
cognitive processing abilities during ambulation.
Proteinopathy Imaging and Gait Disturbances
in PD: Amyloidopathy
The Sydney Multicenter Study of Parkinson’s Dis-
ease revealed that longer duration of disease is increas-
ingly accompanied by postmortem evidence of
comorbid Alzheimer pathology, especially after 5
years.48 This time span agrees with epidemiological
studies indicating the increasing dopamine unrespon-
siveness of (axial) motor symptoms in PD.49 We
recently reported on the relation between postural
instability and gait difficulty (PIGD) feature severity
and neocortical b-amyloid burden in patients with PD
who were at risk for developing dementia using [11C]-
Pittsburgh compound B (PiB) PET.50 We observed
that increased PIGD feature severity was significantly
associated with increased neocortical b-amyloid bur-
den after controlling for effects of possible confound-
ing variables, such as the degree of striatal
dopaminergic denervation, age, and the degree of cog-
nitive capacity impairment. These results are further
substantiated by our preliminary finding of an associa-
tion between higher neocortical b-amyloid burden and
cadence (steps per minute). In contrast, there was no
association between cadence and the degree of striatal
dopaminergic denervation. It is noteworthy that the
TABLE 3. Neurotransmitter imaging studies in PD patients with gait difficulties or history of falls
Imaging technique References Patient populations Findings
AChE [11C]-PMP PET Bohnen et al.44,45 PD fallers vs nonfallers Decreased cholinergic PPN-thalamic activity
in PD fallers without difference in striatal
dopamine loss
AChE [11C]-PMP PET Gilman et al.72 PD and atypical parkinsonian syndromes Greater severity of gait and balance difficul-
ties correlated with more severe choliner-
gic losses in the brainstem and
cerebellum
AChE [11C]-PMP PET Bohnen et al.47 PD and controls Gait speed is not significantly slower than
normal in PD patients with predominant
nigrostriatal dopaminergic denervation but
significantly slower in the PD subgroup
with forebrain cholinopathy
AChE, acetylcholinesterase; [11C]-PMP PET, 1-(carbon-11)methylpiperidin-4-yl propionate positron emission tomography; PPN, pedunculopontine nucleus.
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inability to control cadence is associated with FOG in
PD.51 These findings suggest that even low levels of
comorbid neocortical amyloidopathy may significantly
exacerbate gait impairments in PD.
Discussion
Neuroimaging studies of network functions provide
support for a proposed model in which a corticostria-
tal loop of motor control involves functions of voli-
tion, cognition, and attention. In contrast, a
subcortical-brainstem system seems to be required for
the automatic regulation and modulation of muscle
tone and rhythmic limb movements.24,52 Studies of
FOG in PD emphasize the disruption of cortical (par-
ticularly orbitofrontal and parietal) functions related
to this complex gait disorder. Imaging studies also
identify the PPN and its thalamic and cerebellar con-
nections as key network changes important for rhyth-
mic functions of gait and postural control.53
Gait and balance impairments in PD probably result
from an intricate interplay of multisystem degenerations
and neurotransmitter deficiencies. The hypothesis of a
progressive extension of the degenerative process to
nondopaminergic structures controlling locomotion has
been put forward; and deficiencies in other neurotrans-
mission systems involving acetylcholine, serotonin, and
norepinephrine also have been evoked.10 PET imaging
studies have demonstrated novel evidence of an extra-
striatal nondopaminergic mechanism underlying gait
and postural disturbances in PD: cholinergic denervation
and cortical b-amyloid deposition. Therefore, the emer-
gence of dopamine nonresponsive gait and postural
problems may reflect the transition from a predomi-
nantly hypodopaminergic disorder to a multisystem neu-
rodegenerative disorder involving cholinergic and other
neurotransmitter projections. It is conceivable that corti-
cal amyloid pathology may exert a disruptive effect on
intrinsic cortical functions of motor control or may dis-
rupt important subcortical (basal ganglia, thalamic, and
cerebellar) to cortical connections. Although serotoni-
nergic denervation can be prominent in PD, at least in
the forebrain, as demonstrated by serotonin transporter
[11C]-labeled 3-amino-4-(2-dimethylaminomethyl-phe-
nylsulfanyl)benzonitrile (DASB) PET imaging,54 there
have been no published reports of a relation between
gait and serotoninergic imaging studies. However, it is
interesting to note that greater serotoninergic denerva-
tion has been associated with greater b-amyloid deposi-
tion in PD, particularly in the striatum.55
Future Directions
Need for Improved Understanding of the Role of
the Cerebellum in Parkinsonian Gait
The cerebellum receives massive real-time sensory
input. Proprioceptive sensory information is used not
only to regulate ongoing movements but also to main-
tain stable standing posture.52 The cerebellar locomo-
tor region, which is thought to regulate speed and
gives rhythmical impulses to the brainstem and spinal
cord,56 remains a largely unexplored area of research
in parkinsonian gait. Functional MRI studies have
demonstrated dynamic changes in cerebellar thalamo-
cortical motor circuitry with increased cerebellar
recruitment during disease progression.57 This is in
keeping with the volumetric MRI findings of cerebellar
atrophy only in older PD patients.58 Studies in the
monkey have shown that, along with the well estab-
lished cerebellothalamic projection, there is also a pro-
jection from the deep cerebellar nuclei to the PPN
(cerebellotegmental projection).59 The recent develop-
ment of a novel vesicular acetylcholine transporter
(VAChT) PET ligand, [18F]fluoroethoxybenzovesami-
col (FEOBV), provides an unprecedented opportunity
to quantify cholinergic terminals, particularly PPN
projections to the cerebellum. Our early observation
of dense cerebellar vermis VAChT expression in our
preliminary PET studies (Fig. 2) implicates an impor-
tant cholinergic modulation of cerebellar control of
posture. The use of VAChT imaging may provide a
novel tool for exploring cholinergic cerebellar func-
tions of PD mobility changes.
Need for Improved Understanding of the Role of
Noradrenergic Denervation in Parkinsonian Gait
Noradrenergic pathways have been implicated in
alertness and other cortical attention functions impor-
tant for gait control in PD.60 The locus coeruleus is a
small nucleus located in the pontine tegmentum and is
the main source of norepinephrine for the brain and
spinal cord.61 There is significant degeneration of the
locus coeruleus in PD.62 We have preliminary findings
indicating that cardiac postganglionic sympathetic
FIG. 2. Normal biodistribution of vesicular acetylcholine transporters
using the [18F]fluoroethoxybenzovesamicol ligand is illustrated. More
prominent uptake is observed in areas important for attention and
sensorimotor locomotor functions. 1o SM cortex indicates primary
sensorimotor cortex; PPN/LDTN, pedunculopontine nucleus-
laterodorsal tegmental complex.
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denervation correlates with gait velocity in PD inde-
pendent from the degree of nigrostriatal denervation.63
However, it remains uncertain whether cardiac sympa-
thetic denervation can be taken as a proxy for central
noradrenergic degeneration in PD. Future research
using novel ligands that allow direct quantitative
assessment of central noradrenergic activity is
needed.64
Need to Correlate Imaging Findings With
Neurophysiology of Gait
Advanced MRI techniques are providing optimal
spatial resolution. Ultrahigh-field scanners ( 7.0
Telsa) and quantitative MRI techniques, including dif-
fusion tensor MRI and susceptibility-weighted imag-
ing, hold substantial promise for an accurate
quantification of tissue injury in involved brain areas.
Combined with sophisticated postprocessing, such as
voxel-wise mapping and tractography, these techni-
ques are contributing to the characterization of in vivo
pathologic substrates of the clinical manifestations of
PD.65 What is lacking so far is a good correlation of
the imaging findings and parameters like gait variabili-
ty, dual task cost, or frequency of falls based on quan-
titative gait and postural assessments. Studies that
combine imaging and quantitative gait assessment will
help to elucidate how the brain network interacts with
gait and postural control.
Need to Correlate Selective Stimulation Protocols
in Deep Brain Stimulation to More Accurately
Predict Connectivity Patterns and Interaction of
Specific Centers in the Supraspinal Locomotor
Network of Parkinsonian Gait
Selective stimulation of implanted DBS targets com-
bined with rCBF imaging can provide a unique experi-
ment of nature to better characterize the connectivity
patterns of the various locomotor centers underlying
parkinsonian gait. For example, the recent study by
Hill and colleagues provides early evidence that the
effects of STN DBS on gait may be mediated by differ-
ent circuits through basal ganglia-thalamocortical ver-
sus cerebellar-thalamocortical circuits.33,34 Recordings
of local field potential from implanted electrodes can
provide additional important physiological informa-
tion about gait parameters at key locomotor areas,
such as the PPN.66
Need for Standardized Paradigms for Functional
Imaging in PD
Emerging areas for future development include the
development of new fMRI motor imagery paradigms,
the use of portable devices (fNIRS, EEG), and the
application of multimodal imaging (EEG-fMRI, PET-
fMRI). However, it will be crucial to define standards
for finding the best method for a given research ques-
tion. fMRI remains the best method for depicting sub-
cortical structures and for repetitive measurements.
EEG has excellent temporal resolution and will make
it possible to investigate changes in brain activity dur-
ing the gait cycle. A recent study by Handojoseno
et al. successfully demonstrated the feasibility surface
EEG and quantitative analysis for the early detection
of FOG in PD that may appear electrically 5 seconds
before the clinical symptoms.67 FDG-PET is well
suited for cognitively impaired patients, because it
does not require the same amount of cooperation as
fMRI with MI of gait.
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